Back
AeroVironment Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
25
AVAV
AeroVironment
Last Price:
$121.56
Seasonality Move:
7.94%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$99.80
Seasonality Move:
6.73%
Sell
25
AeroVironment (AVAV)
is a Sell
Is AeroVironment a Buy, Sell or Hold?
-
The current AeroVironment [AVAV] share price is $124.00. The Score for AVAV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
AVAV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AVAV Stock Price Chart
What is AeroVironment's stock price today?
-
The AeroVironment share price today is $124.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVAV is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $100.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVAV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.46 | Sell |
Relative Strength Index (14 RSI): | 20.96 | Sell |
Chaikin Money Flow: | 1101 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (141.4 - 176.56) | Sell |
Bollinger Bands (100): | (154.11 - 206.95) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.22 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | 544784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.87 - 112.63) | Sell |
Bollinger Bands (100): | (110.05 - 127.23) | Sell |
AVAV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 139.15 | Sell |
20-day SMA: | 153.51 | Sell |
50-day SMA: | 162.74 | Sell |
200-day SMA: | 184.26 | Sell |
8-day EMA: | 137.68 | Sell |
20-day EMA: | 149.52 | Sell |
50-day EMA: | 161.88 | Sell |
200-day EMA: | 172.06 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.91 | Sell |
20-day SMA: | 106.68 | Sell |
50-day SMA: | 114.29 | Sell |
200-day SMA: | 126.68 | Sell |
8-day EMA: | 104.06 | Sell |
20-day EMA: | 106.89 | Sell |
50-day EMA: | 112.29 | Sell |
200-day EMA: | 121 | Sell |
AeroVironment Earnings Growth & AVAV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $1.13 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
AeroVironment Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |